We injected AMD3100 (5 mg·kg−1, i.p.)daily into miR‐126ΔIEC mice following AOM/DSS treatment to determine the function of CXCL12 in miR‐126ΔIEC mice during CAC development. This evidence concerns the gene CXCL12 and infectious otitis media.